4 months ago
69
ARTICLE AD BOX
Corona Remedies, made a stellar debut connected Dalal Street connected Monday, entering with a 38.42% premium implicit the IPO terms of Rs 1,062.The stock volition beryllium disposable for trading connected NSE and BSE.On the National Stock Exchange, Corona Remedies was trading astatine 1470, and astatine 1473, up 1.45% connected the BSE, astir 11:11 AM.
Corona Remedies IPO
The Rs 655-crore initial nationalist offering, afloat structured arsenic an connection for sale, saw an overwhelming effect from investors. The contented was oversubscribed 144.5 times overall, driven by organization investors. Qualified organization buyers subscribed astir 294 times, non-institutional investors implicit 220 times, and retail investors besides participated strongly, taking up their allocation much than 30 times, according to ET.
This request highlighted beardown assurance successful the company’s concern strategy, merchandise range, and net potential.Corona Remedies did not rise caller superior done the IPO and each proceeds went to selling shareholders. The institution entered the nationalist markets with a steadfast equilibrium expanse and a grounds of accordant profitability. Based connected the IPO price, the company’s marketplace valuation stands astatine astir Rs 6,495 crore, with a post-issue price-to-earnings aggregate of astir 35 times, calculated utilizing annualised FY26 earnings.
While the valuation is connected the higher side, investors look consenting to wage a premium for dependable growth, precocious margins, and enactment successful prime therapy areas.
Financial scoreboard
The institution has shown beardown maturation financially. Revenue for FY25 roseate 18% year-on-year to Rs 1,202 crore, portion nett aft taxation jumped 65% to Rs 149 crore. For the 4th that ended successful June 2025, PAT stood astatine Rs 46 crore, signalling sustained momentum into FY26.
Return ratios stay robust, with ROE astatine 27.5% and ROCE implicit 41%, aided by disciplined superior absorption and a debased debt-to-equity ratio of 0.1.Anchor investors had already committed adjacent to Rs 195 crore earlier the IPO, lending credibility and stableness to the offering. The information of long-only home and planetary funds successful the anchor publication helped acceptable the code for beardown organization request during the nationalist sale.
About Corona Remedies
Corona Remedies focuses connected women’s healthcare, cardiology, symptom management, urology, and different chronic therapies. The firm’s organisation web spans 22 states and has implicit 2,600 aesculapian representatives.
